Article Text
Abstract
We present the rare case of a 61-year-old man with Crohn’s disease who developed a cutaneous Kaposi’s sarcoma in the setting of long-term treatment with 6-mercaptopurine. Deciding on the best course of management provided a clinical challenge in an ‘evidence-light’ area. Relevant case reports and guidelines were reviewed. In general, the withdrawal of immunosuppressive therapy is advised; however, a multidisciplinary, case-by-case approach is also emphasised. The patient’s lesion was removed and, following collaborative discussion, immunosuppression was continued post resection. This is thought to be the first reported case involving a Kaposi’s sarcoma in inflammatory bowel disease where immune therapy was not subsequently discontinued.
- malignant disease and immunosuppression
- Crohn's disease
- dermatology
Statistics from Altmetric.com
Footnotes
Contributors RDC: primary author; integral in designing and drafting the case report and coordinating the contributing members. DG: involved in conception, review and editing each draft, as well as approval on the final published work. GH: substantial contribution to the dermatology aspects of the report, as well as editing advice in the wider sense, and approval on the final published work. WR: substantial contribution to the pathology aspects of the report as well as approval on the final published work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.